KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

PARLODEL 2.5 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

2.5 MG

 

GENERIC NAME:

BROMOCRIPTINE

 

MANUFACTURER:

NOVARTIS PHARMA

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Acromegaly

Adenoma, prolactin- secreting

Hyperprolactinemia

Parkinson's disease

 

SIDE EFFECTS:

Confusion

dyskinesia

hallucinations

Myocardial infarction

seizures or strokes

Cerebrospinal fluid rhinorrhea

fainting

gastrointestinal hemorrhage or peptic ulcer

retroperitoneal fibrosis

Hypotension, especially orthostatic hypotension

nausea

Constipation

diarrhea

drowsiness or tiredness

dry mouth

leg cramps at night

loss of appetite

mental depression

Raynaud's phenomenon

stomach pain

stuffy nose

vomiting

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Hepatic function impairment

Hypertension,

Hypertension, pregnancy-induced

Psychiatric disorders

 

ADULT DOSE:

Amenorrhea, secondary, due to hyperprolactinemia or Galactorrhea due to hyperprolactinemia or Hypogonadism, male, due to hyperprolactinemia or Infertility due to hyperprolactinemia-Initial: Oral, 1.25 to 2.5 mg at bedtime with a snack. Dosage may be increased by 2.5 mg every three to seven days as needed to a total of 5 to 7.5 mg a day taken in divided doses with meals . Maintenance: Oral, 2.5 mg two or three times a day with meals. Doses of up to 15 mg have been used . Prolactinomas, pituitary-Initial: Oral, 1.25 mg two or three times a day with meals. Dosage adjustment is gradual over several weeks to 10 to 20 mg a day taken in divided doses with meals . Occasionally, higher doses may be required . Maintenance: Oral, 2.5 to 20 mg a day taken in divided doses with meals . Parkinsonism-Initial: Oral, 1.25 mg one or two times a day with meals; for single doses, at bedtime with a snack is preferred. Dosage may be increased by 2.5 mg increments every fourteen to twenty-eight days . Maintenance: Oral, 2.5 to 40 mg a day, taken in divided doses with meals. Although higher doses have been used, safety and efficacy have not been established with doses greater than 100 mg a day . Acromegaly-Initial: Oral, 1.25 to 2.5 mg at bedtime with a snack for 3 days; dosage may be increased by 1.25 or 2.5 mg every three to seven days up to 30 mg a day taken in divided doses with meals or at bedtime with a snack . Maintenance: Oral, 10 to 30 mg a day taken in divided doses with meals or at bedtime with a snack. Up to 100 mg per day has been used . [Lactation suppression] -Initial: Oral, 2.5 mg twice a day taken with meals. Patient may begin medication only after vital signs stabilize and no sooner than four hours after delivery . Maintenance: Oral, 2.5 to 7.5 mg a day taken in divided doses with meals or at bedtime with a snack for fourteen days. Has been used for up to twenty-one days if needed . [Neuroleptic malignant syndrome] -Initial: Oral, 5 mg once a day taken at bedtime with a snack; dosage adjustment titrated according to patient response by 2.5 mg increments a day as needed, taken in divided doses with meals or at bedtime with a snack . Maintenance: Oral, up to 20 mg a day taken in divided doses with meals or at bedtime with a snack .

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Children up to 15 years of age: Dosage has not been established . Children 15 years of age and older: See Usual adult dose .  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT